Cargando…
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
ABCB1 is one of the major drug efflux transporters that is known to cause multidrug resistance (MDR) in cancer patients receiving chemotherapy for the treatment of solid tumors and hematological malignancies. Inhibition of ABCB1 efflux function is important for maintaining the intracellular concentr...
Autores principales: | Gupta, Pranav, Gao, Hai-Ling, Ashar, Yunali V., Karadkhelkar, Nishant M., Yoganathan, Sabesan, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358874/ https://www.ncbi.nlm.nih.gov/pubmed/30641875 http://dx.doi.org/10.3390/ijms20020268 |
Ejemplares similares
-
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
por: Gao, Hai-Ling, et al.
Publicado: (2020) -
Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study
por: Narayanan, Silpa, et al.
Publicado: (2022) -
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance
por: Narayanan, Silpa, et al.
Publicado: (2021) -
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
por: Ashar, Yunali V., et al.
Publicado: (2020) -
Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function
por: Ashar, Yunali, et al.
Publicado: (2022)